Japan to Consider Early Approval for Shionogi COVID Pill

The Japanese Prime Minister has said the government would consider granting conditional early approval for the oral COVID-19 treatment being developed by Shionogi.
Reuters Health Information

source https://www.medscape.com/viewarticle/967988?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost